What is the choice of treatment for hairy cell leukemia?
Golomb
H M
HM
University of Chicago Medical Center, Michael Reese Hospital and Medical Center.
Ratain
M J
MJ
Moormeier
J
J
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003070:Coformycin / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use; D007943:Leukemia, Hairy Cell / Q000628:therapy*; D015649:Pentostatin; D011994:Recombinant Proteins; D012074:Remission Induction; D012263:Ribonucleosides / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D007370:Interferon Type I; D011994:Recombinant Proteins; D012263:Ribonucleosides; D003070:Coformycin; D015649:Pentostatin